Design of a Bacteriophage Cocktail Active against Shigella Species and Testing of Its Therapeutic Potential in Galleria mellonella
Authors:
- Andrey A. FilippovAndrey A. Filippov
- Wanwen SuWSWanwen Su
- Kirill V. SergueevKSKirill V. Sergueev
- Richard T. KevorkianRKRichard T. Kevorkian
- Erik C. SnesrudESErik C. Snesrud
- Apichai SrijanASApichai Srijan
- Yunxiu HeYHYunxiu He
- Derrick E. FoutsDFDerrick E. Fouts
- Woradee LurchachaiwongWLWoradee Lurchachaiwong
- Patrick T. McGannPMPatrick T. McGann
- Damon W. EllisonDEDamon W. Ellison
- Brett E. SwierczewskiBSBrett E. Swierczewski
Open Access
- 19 November 2022
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 11 (11) , 1659
Abstract
Shigellosis is a leading global cause of diarrheal disease and travelers’ diarrhea now being complicated by the dissemination of antibiotic resistance, necessitating the development of alternative antibacterials such as therapeutic bacteriophages (phages). Phages with lytic activity against Shigella strains were isolated from sewage. The genomes of 32 phages were sequenced, and based on genomic comparisons belong to seven taxonomic genera: Teetrevirus, Teseptimavirus, Kayfunavirus, Tequatrovirus, Mooglevirus, Mosigvirus and Hanrivervirus. Phage host ranges were determined with a diverse panel of 95 clinical isolates of Shigella from Southeast Asia and other geographic regions, representing different species and serotypes. Three-phage mixtures were designed, with one possessing lytic activity against 89% of the strain panel. This cocktail exhibited lytic activity against 100% of S. sonnei isolates, 97.2% of S. flexneri (multiple serotypes) and 100% of S. dysenteriae serotypes 1 and 2. Another 3-phage cocktail composed of two myophages and one podophage showed both a broad host range and the ability to completely sterilize liquid culture of a model virulent strain S. flexneri 2457T. In a Galleria mellonella model of lethal infection with S. flexneri 2457T, this 3-phage cocktail provided a significant increase in survival.Keywords
Funding Information
- Defense Health Program through Military Infectious Disease Research Program (D0559_17_WR)
- WRAIR command
- Congressionally Directed Medical Research Programs (PR182667)
This publication has 85 references indexed in Scilit:
- T4-Like Phage Bp7, a Potential Antimicrobial Agent for Controlling Drug-Resistant Escherichia coli in ChickensApplied and Environmental Microbiology, 2013
- Post‐Infectious Sequelae of Travelers' DiarrheaJournal of Travel Medicine, 2013
- Bacteriophages for managingShigellain various clinical and non-clinical settingsBacteriophage, 2013
- Case-Control Study of Diarrheal Disease Etiology in a Remote Rural Area in Western ThailandThe American Journal of Tropical Medicine and Hygiene, 2010
- Bacteriophage Administration Reduces the Concentration ofListeria monocytogenesin the Gastrointestinal Tract and Its Translocation to Spleen and Liver in Experimentally Infected MiceInternational Journal of Microbiology, 2010
- Experimental Bacteriophage Therapy Increases Survival of Galleria mellonella Larvae Infected with Clinically Relevant Strains of the Burkholderia cepacia ComplexAntimicrobial Agents and Chemotherapy, 2009
- Diarrheal illness among deployed U.S. military personnel during Operation Bright Star 2001—EgyptDiagnostic Microbiology and Infectious Disease, 2005
- Complete Nucleotide Sequence and Likely Recombinatorial Origin of Bacteriophage T3Journal of Molecular Biology, 2002
- Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elementsJournal of Molecular Biology, 1983
- The Genetics of T-ODD PhagesAnnual Review of Microbiology, 1973